Working toward a dramatic shift in the treatment of peripheral blockages

PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions.

PQ Bypass is a former Company-In-Residence at the Fogarty Institute for Innovation and is operated by recognized leaders in the medical device industry. Our executive team members have held senior leadership positions at companies including Medtronic, Abbott, Johnson & Johnson, Covidien, and Stryker and also have extensive experience developing medical devices for venture-backed startups such as Evalve, AccessClosure, Altura, and DVI.

Our goal is to reduce patient hardship along with the morbidity and mortality associated with more invasive procedures and to ultimately improve the quality-of-life for patients with peripheral artery disease

The underlying technology and technique used in the percutaneous PQ Bypass procedure was co-developed by two world-renowned cardiologists and innovators, Dr. James Joye (El Camino Hospital, Mountain View, California) and Dr. Richard Heuser (St. Luke’s Hospital, Phoenix, Arizona), who are internationally recognized experts in peripheral artery disease (PAD).

side by side

Management Team

Peter Wehrly – President & CEO

Pete joined PQ Bypass in 2016 and brings over 25 years of experience in the medical device field.  He has served as Group President for Covidien, Senior Vice President for Medtronic and worked in Sales & Marketing Management for DePuy Orthopedics. Pete currently serves on the Board of Directors of Synaptive Medical and Re-Walk Robotics.

Steven Tyler – Vice President, Research & Development

Steve has over 20 years of experience in the medical device industry leading Research & Development teams.  He has held management positions at Stryker, Guidant, Abbott Vascular (Evalve) and Avinger. Steve holds a Master’s Degree in Mechanical Engineering from Stanford University and is a licensed Professional Engineer.

Ziad Rouag – Vice President, Regulatory & Clinical Affairs

Ziad has over 20 years of experience in medical device managing clinical and regulatory affairs. He has served as Vice-President of RA/CA/QA at Altura, Avinger, and Auxogyn and Director of Reg/Clin. at Guidant, Johnson & Johnson, and Abbott Vascular (Evalve). Ziad has degrees in biology and economics from McGill University and a Juris Doctor from Rutgers University.

Heather Simonsen – Vice President, Global Marketing

Heather has over 20 years of experience in the healthcare industry. She has served in senior roles for venture-funded medtech startups and Fortune 500 companies such as Abbott and Johnson & Johnson. Heather completed the Executive Program at Dartmouth’s Tuck School of Business and holds an MBA from Chicago’s DePaul School of Business. She has held board positions with the Medical Marketing Association, Healthcare Businesswomen’s Association, and is on the founders board of advisors for the Stanford University-affiliated StartX Accelerator.

Scott Hosaka – Vice President, Quality & Operations

Scott has over 25 years experience in the medical industry at venture-funded start-ups and Fortune 500 corporations like DVI, Guidant, Johnson & Johnson, and Eli Lilly. He has served as Vice President of Operations and Quality for multiple medical start-ups and as Principal Consultant for medical and cleantech companies. Scott holds a Biomedical Engineering degree from Northwestern University.

Board of Directors

Richard Ferrari / DeNovo Ventures
Kenneth Hayes / Ascent Biomedical Ventures
James D. Joye, DO / Founder
David Neustaedter / Medtronic
Daniel O’Mahony / Seroba Life Sciences
Chris Owens / President & CEO, Gynesonics
Peter Wehrly / President & CEO, PQ Bypass

 

Investors

Ascent Biomedical Ventures
Seroba Life Sciences